POAI 0.89 (-21.24%)
US74039M2008• Medical Devices & Instruments• Medical Instruments & Supplies
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. POAI

Predictive Oncology (POAI) Competitor Comparison

We are evaluating the key criteria listed to compare Predictive Oncology (POAI) against its competitors in the Medical Instruments & Supplies industry.

Market Capitalization

43 / 44

Gross Profits

38 / 40

Total Revenue

41 / 43

EBITDA

35 / 44

Free Cashflow

36 / 44

Quick Ratio

14 / 44

Earnings per Share

41 / 44

Dividend yield

0 / 13

Total Cash

35 / 44

Performance 3 years

44 / 44

Performance 5 years

44 / 44

Performance 10 years

44 / 44

Linearity 3 years

39 / 44

Linearity 5 years

43 / 44

Linearity 10 years

34 / 44

Total Rank

22 / 44

Dividend Rank

33 / 44

Valuation Rank

38 / 44

Piotroski Rank

32 / 44

Muliplier Rank

21 / 44

Linearity 3 years - POAI ranking 39 / 44

These are the competitors of Predictive Oncology in the industry Medical Instruments & Supplies ranked by linearity 3 years
1. Becton, Dickinson BDX
173.35
2. Steris STE
36.86
3. West Pharmaceutical Services WST
26.95
4. Cooper Companies COO
25.2
5. Hologic HOLX
19.85
6. ResMed RMD
12.28
7. Utah Medical Products UTMD
9.78
8. Atrion ATRI
8.45
9. Bausch & Lomb BLCO
7.55
10. Alcon ALC
7.25
11. Merit Medical Systems MMSI
6.84
12. Haemonetics HAE
6.82
13. Repligen RGEN
6.76
14. iRhythm Technologies IRTC
5.03
15. LeMaitre Vascular LMAT
5
16. NexGel NXGL
4.99
17. ICU Medical ICUI
4.6
18. Pro-Dex PDEX
4.44
19. Ansell PD1.F
4.26
20. KORU Medical Systems KRMD
4.21
21. Masimo MASI
3.96
22. Glaukos GKOS
3.69
23. Envista Holdings NVST
3.64
24. Teleflex TFX
3.58
25. OraSure Technologies OSUR
3.56
26. Baxter BAX
3.36
27. Pulse Biosciences PLSE
3.27
28. Dentsply Sirona XRAY
3.11
29. BioLife Solutions BLFS
3.02
30. Harvard Bioscience HBIO
2.95
31. NeuroMetrix NURO
2.93
32. AtriCure ATRC
2.71
33. AngioDynamics ANGO
2.41
34. Intuitive Surgical ISRG
2.37
35. Microbot Medical MBOT
2.24
36. Staar Surgical STAA
2.24
37. Akoya Biosciences AKYA
2.16
38. Warby Parker WRBY
2.02
39. Predictive Oncology POAI
1.92
40. Nephros NEPH
1.89
41. Ekso Bionics Holdings EKSO
1.89
42. electroCore ECOR
1.81
43. NovoCure NVCR
1.65
44. Femasys FEMY
1.52
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.